Neuraxis, Inc (NRXS): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$59.5K
Year ended 2025-12-31
$73.2K
Trailing 12 months to 2026-06-30
+17.0%
3-year compound annual growth
2022-12-31: $37.1K2023-12-31: $40.7K2024-12-31: $37.8K2025-12-31: $59.5K$59.5K
2022-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$59.5K+57.3%2026-03-19, From 2025-01-01
2024-12-31$37.8K-7.1%2026-03-19, From 2024-01-01
2023-12-31$40.7K+9.7%2025-03-20, From 2023-01-01
2022-12-31$37.1Kn/a2024-04-16, From 2022-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Neuraxis, Inc (NRXS)2025-12-31$59.5K+57.3%
ADM Tronics Unlimited, Inc. (ADMT)2026-03-31$6.8K-6.7%
Hongchang International Co., Ltd (HCIL)2024-12-31$90.5K+2.7%
Nuwellis, Inc. (NUWE)2025-12-31$200.0K-35.5%
Escalon Medical Corp (ESMC)2025-06-30$37.8K-17.8%
CapsoVision, Inc (CV)2025-12-31$216.0K+4.9%
QT Imaging Holdings, Inc. (QTI)2025-12-31$131.0K-43.3%
Precision Optics Corporation, Inc. (POCI)2025-06-30$212.4K0.0%
electroCore, Inc. (ECOR)2025-12-31$501.0K-34.1%

Compare NRXS, ADMT, HCIL, NUWE side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗